Altered Dermal Fibroblast Behavior in a Collagen V Haploinsufficient Murine Model of Classic Ehlers-Danlos Syndrome

Overview

Journal Connect Tissue Res

Publisher Informa Healthcare

Date 2015 Dec 30

PMID 26713685

Citations 16

Authors

John DeNigris

Qingmei Yao

Erika K Birk

David E Birk

Affiliations

Soon will be listed here.

Abstract

Mutations in collagen V are associated with classic Ehlers-Danlos syndrome (EDS). A significant percentage of these mutations result in haploinsufficiency for collagen V. The purpose of this work was to determine if changes in collagen V expression are associated with altered dermal fibroblast behavior contributing to the poor wound healing response. A haploinsufficient Col5a1(+/-) mouse model of EDS was utilized. In vivo wound healing studies demonstrated that mutant mice healed significantly slower than Col5a1(+/+) mice. The basis for this difference was examined in vitro using dermal fibroblast strains isolated from Col5a1(+/-) and Col5a1(+/+) mice. Fibroblast proliferation was determined for each strain by counting cells at different time points after seeding as well as using the proliferation marker Ki-67. Fibroblast attachment to collagens I and III and fibronectin also was analyzed. In addition, in vitro scratch wounds were used to analyze fibroblast wound closure. Significantly decreased fibroblast proliferation was observed in Col5a1(+/-) compared to Col5a1(+/+) fibroblasts. Our data indicate that the decreased fibroblast number was not due to apoptosis. Wildtype Col5a1(+/+) fibroblasts attached significantly better to components of the wound matrix (collagens I and III and fibronectin) than Col5a1(+/-) fibroblasts. A significant difference in in vitro scratch wound closure rates also was observed. Col5a1(+/+) fibroblasts closed wounds in 22 h, while Col5a1(+/-) fibroblasts demonstrated ~80% closure. There were significant differences in closure at all time points analyzed. Our data suggest that decreased fibroblast proliferation, extracellular matrix attachment, and migration contribute to the decreased wound healing response in classic EDS.

Citing Articles

Regulation of Joint Tissues and Joint Function: Is There Potential for Lessons to Be Learned Regarding Regulatory Control from Joint Hypermobility Syndromes?.

Hart D Int J Mol Sci. 2025; 26(3).

PMID: 39941023 PMC: 11818925. DOI: 10.3390/ijms26031256.

Type V collagen exhibits distinct regulatory activities in TMJ articular disc versus condylar cartilage during postnatal growth and remodeling.

Chandrasekaran P, Alanazi A, Kwok B, Li Q, Viraraghavan G, Balasubramanian S Acta Biomater. 2024; 189:192-207.

PMID: 39362448 PMC: 11640222. DOI: 10.1016/j.actbio.2024.09.046.

Modulating the extracellular matrix to treat wound healing defects in Ehlers-Danlos syndrome.

Kelly-Scumpia K, Archang M, Purbey P, Yokota T, Wu R, McCourt J iScience. 2024; 27(9):110676.

PMID: 39262784 PMC: 11389543. DOI: 10.1016/j.isci.2024.110676.

Dysfunctional latent transforming growth factor β activation after corneal injury in a classical Ehlers-Danlos model.

Sun M, Acosta A, Emerick V, Adams S, Avila M, Margo C Matrix Biol. 2024; 128:21-30.

PMID: 38340967 PMC: 10996040. DOI: 10.1016/j.matbio.2024.02.004.

Collagen V haploinsufficiency in female murine patellar tendons results in altered matrix engagement and cellular density, demonstrating decreased healing.

Carlson J, Shetye S, Sun M, Weiss S, Birk D, Soslowsky L J Orthop Res. 2023; 42(5):950-960.

PMID: 37975633 PMC: 11009080. DOI: 10.1002/jor.25740.

References

Burrows N, Nicholls A, Richards A, Luccarini C, Harrison J, Yates J . A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families. Am J Hum Genet. 1998; 63(2):390-8. PMC: 1377290. DOI: 10.1086/301948. View

Wenstrup R, Florer J, Brunskill E, Bell S, Chervoneva I, Birk D . Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem. 2004; 279(51):53331-7. DOI: 10.1074/jbc.M409622200. View

Malfait F, De Paepe A . Molecular genetics in classic Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2005; 139C(1):17-23. DOI: 10.1002/ajmg.c.30070. View

Wenstrup R, Florer J, Davidson J, Phillips C, Pfeiffer B, Menezes D . Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem. 2006; 281(18):12888-95. DOI: 10.1074/jbc.M511528200. View

Berendsen A, Bronckers A, Smit T, Walboomers X, Everts V . Collagen type V enhances matrix contraction by human periodontal ligament fibroblasts seeded in three-dimensional collagen gels. Matrix Biol. 2006; 25(8):515-22. DOI: 10.1016/j.matbio.2006.07.006. View

Liang C, Park A, Guan J . In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007; 2(2):329-33. DOI: 10.1038/nprot.2007.30. View

Symoens S, Malfait F, Renard M, Andre J, Hausser I, Loeys B . COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome. Hum Mutat. 2008; 30(2):E395-403. DOI: 10.1002/humu.20887. View

Malfait F, Wenstrup R, De Paepe A . Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med. 2010; 12(10):597-605. DOI: 10.1097/GIM.0b013e3181eed412. View

Wenstrup R, Smith S, Florer J, Zhang G, Beason D, Seegmiller R . Regulation of collagen fibril nucleation and initial fibril assembly involves coordinate interactions with collagens V and XI in developing tendon. J Biol Chem. 2011; 286(23):20455-65. PMC: 3121453. DOI: 10.1074/jbc.M111.223693. View

10.

Smith S, Birk D . Focus on molecules: collagens V and XI. Exp Eye Res. 2010; 98:105-6. PMC: 2996481. DOI: 10.1016/j.exer.2010.08.003. View

11.

De Paepe A, Malfait F . The Ehlers-Danlos syndrome, a disorder with many faces. Clin Genet. 2012; 82(1):1-11. DOI: 10.1111/j.1399-0004.2012.01858.x. View

12.

Scholzen T, Gerdes J . The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000; 182(3):311-22. DOI: 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9. View

13.

Birk D . Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2000; 32(3):223-37. DOI: 10.1016/s0968-4328(00)00043-3. View

14.

Niyibizi C, Kavalkovich K, Yamaji T, Woo S . Type V collagen is increased during rabbit medial collateral ligament healing. Knee Surg Sports Traumatol Arthrosc. 2000; 8(5):281-5. DOI: 10.1007/s001670000134. View

15.

Reinke J, Sorg H . Wound repair and regeneration. Eur Surg Res. 2012; 49(1):35-43. DOI: 10.1159/000339613. View

16.

Symoens S, Syx D, Malfait F, Callewaert B, De Backer J, Vanakker O . Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. Hum Mutat. 2012; 33(10):1485-93. DOI: 10.1002/humu.22137. View

17.

Malfait F, De Paepe A . The Ehlers-Danlos syndrome. Adv Exp Med Biol. 2014; 802:129-43. DOI: 10.1007/978-94-007-7893-1_9. View

18.

Sun M, Connizzo B, Adams S, Freedman B, Wenstrup R, Soslowsky L . Targeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos syndrome joint phenotype. Am J Pathol. 2015; 185(5):1436-47. PMC: 4419209. DOI: 10.1016/j.ajpath.2015.01.031. View

19.

Wenstrup R, Florer J, Willing M, Giunta C, Steinmann B, Young F . COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet. 2000; 66(6):1766-76. PMC: 1378044. DOI: 10.1086/302930. View

20.

Schwarze U, Atkinson M, Hoffman G, Greenspan D, Byers P . Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet. 2000; 66(6):1757-65. PMC: 1378060. DOI: 10.1086/302933. View